Search
Patexia Research
Case number 2017-1451

Par Pharmaceutical, Inc. v. Horizon Therapeutics, LLC > Documents

Date Field Doc. No.Description (Pages)
Apr 23, 2021 0 PAR PHARMACEUTICAL, INC. v. HORIZON THERAPEUTICS, LLC [RULE 36 JUDGMENT] [nonprecedential] (0)
Jul 25, 2018 65 Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [538464] [JAB] [Entered: 07/25/2018 10:40 AM] (0)
Jun 18, 2018 64 OPINION and JUDGMENT filed. The judgment or decision is: Affirmed. (FCR 36). (For the Court: Newman, Circuit Judge; Dyk, Circuit Judge and Taranto, Circuit Judge). [530138] [JAB] [Entered: 06/18/2018 09:28 AM] (0)
Jun 7, 2018 63 Submitted after ORAL ARGUMENT by Aziz Burgy for Par Pharmaceutical, Inc. and Robert Fritz Green for Horizon Therapeutics, LLC. Panel: Judge: Newman , Judge: Dyk , Judge: Taranto. [527635] [JAB] [Entered: 06/07/2018 12:15 PM] (0)
May 15, 2018 62 Response to oral argument order from the Appellant Par Pharmaceutical, Inc.. Designating Aziz Burgy to argue.. Designating 12 minutes for argument. Reserving 3 minutes for rebuttal. [17-1451] [Aziz Burgy] [Entered: 05/15/2018 05:02 PM] (0)
May 8, 2018 61 Response to oral argument order from the Appellee Horizon Therapeutics, LLC. Designating Robert F. Green to argue.. Designating 15 minutes for argument. Reserving 0 minutes for rebuttal. [17-1451] [Robert Green] [Entered: 05/08/2018 09:32 AM] (0)
Apr 20, 2018 60 NOTICE OF CALENDARING. Panel: 1806L. Case scheduled Jun 07, 2018 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 203. Response to oral argument order due: 05/15/2018. Arguing counsel is required to check-in with the Clerk's Office, 4th Floor, Room 401, between 8:30 a.m. and 9:30 a.m. on the day of argument. Please review the Oral Argument Order. [515698] [JAB] [Entered: 04/20/2018 02:12 PM] (0)
Feb 15, 2018 59 Notice from Appellee Horizon Therapeutics, LLC regarding conflicts with oral argument ( Principal attorney is unavailable April 2-3, 2018, due to pre-scheduled travel; April 30-May 3, 2018, due to conference attendance as a speaker in Israel; and July 9, 2018 due to oral argument in separate appeal.). Service: 02/15/2018 by email. [498243] [Robert Green] [Entered: 02/15/2018 05:01 PM] (0)
Feb 5, 2018 57 Notice from Appellant Par Pharmaceutical, Inc. regarding conflicts with oral argument (April 2, 2018, April 5, 2018, June 4, 2018, August 10, 2018, December 7, 2018). Service: 02/05/2018 by email. [495024] [Aziz Burgy] [Entered: 02/05/2018 09:54 AM] (0)
Feb 5, 2018 58 Notice from Appellee Horizon Therapeutics, LLC regarding conflicts with oral argument (Principal attorney is unavailable March 5-9 and 12, 2018, due to a trial; April 2-3, 2018, due to pre-scheduled travel; April 30-May 3, 2018, due to conference attendance and presentation; July 9, 2018, due to oral argument in a separate matter.). Service: 02/05/2018 by email. [495153] [Emer Simic] [Entered: 02/05/2018 01:45 PM] (0)
Jan 30, 2018 56 6 paper copies of the Joint Appendix [54] received from Appellant Par Pharmaceutical, Inc. [493603] [CFT] [Entered: 01/30/2018 10:33 AM] (0)
Jan 29, 2018 55 Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks, or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category.. [493276] [SJ] [Entered: 01/29/2018 10:44 AM] (0)
Jan 25, 2018 53 6 CD's of the Brief for Appellant Par Pharmaceutical, Inc., Brief of Appellee Horizon Therapeutics, LLC and Reply Brief for Appellant Par Pharmaceutical, Inc. received from Appellant Par Pharmaceutical, Inc. [492928] [JCP] [Entered: 01/26/2018 08:50 AM] (0)
Jan 24, 2018 54 APPENDIX FILED for Par Pharmaceutical, Inc. [52]. Number of Pages: 558. Service: 01/24/2018 by email. The paper copies of the brief should be received by the court on or before 02/05/2018. [493275] [SJ] [Entered: 01/29/2018 10:44 AM] (561)
Jan 24, 2018 52 TENDERED from Appellant Par Pharmaceutical, Inc. and Appellee Horizon Therapeutics, LLC. Title: JOINT APPENDIX. Service: 01/24/2018 by email. [492429] [Aziz Burgy] [Entered: 01/24/2018 03:51 PM] (561)
Jan 24, 2018 51 Certificate of Compliance with Fed. Cir. R. 17 (Agency) for Appellant Par Pharmaceutical, Inc.. Service: 01/24/2018 by email. [492408] [David Silverstein] [Entered: 01/24/2018 03:15 PM] (3)
Jan 24, 2018 50 Statement of Compliance with Fed. Cir. R. 33 for Appellant Par Pharmaceutical, Inc. and Appellee Horizon Therapeutics, LLC. Service: 01/24/2018 by email, clerk. [492403] [Aziz Burgy] [Entered: 01/24/2018 03:09 PM] (3)
Jan 22, 2018 49 6 paper copies of the Reply Brief [48] received from Appellant Par Pharmaceutical, Inc. [491268] [SJL] [Entered: 01/22/2018 10:09 AM] (0)
Jan 17, 2018 48 REPLY BRIEF FILED for Appellant Par Pharmaceutical, Inc. [47]. Number of Pages: 24. Service: 01/17/2018 by email. The paper copies of the brief should be received by the court on or before 01/25/2018. Appendix is due 01/24/2018. [490593] [CAB] [Entered: 01/18/2018 09:51 AM] (32)
Jan 17, 2018 47 TENDERED from Appellant Par Pharmaceutical, Inc.. Title: REPLY BRIEF. Service: 01/17/2018 by email. [490483] [Aziz Burgy] [Entered: 01/17/2018 05:01 PM] (32)
Dec 21, 2017 46 6 paper copies of the Opening Response Brief [42] received from Appellee Horizon Therapeutics, LLC. [484694] [JCP] [Entered: 12/21/2017 11:26 AM] (0)
Dec 20, 2017 45 CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: motion to extend time to file reply brief Docket No. [43], ERROR: Motion did not include a certificate of compliance regarding word count. CORRECTION: For future filings, motions filed must follow Fed. R. App. P. 27 and Fed. Cir. R. 27. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [484245] [CAB] [Entered: 12/20/2017 01:21 PM] (0)
Dec 20, 2017 44 **TEXT ONLY** ORDER granting motion to extend time to file reply brief [43] filed by Appellant Par Pharmaceutical, Inc. Reply brief is due 01/17/2018. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [484234] [CAB] [Entered: 12/20/2017 01:10 PM] (0)
Dec 19, 2017 43 MOTION of Appellant Par Pharmaceutical, Inc. to extend the time to 01/17/2018 to file the reply brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 12/19/2017 by email. [483725] [Aziz Burgy] [Entered: 12/19/2017 12:23 PM] (8)
Dec 13, 2017 42 BRIEF FILED for Appellee Horizon Therapeutics, LLC [41]. Number of Pages: 60. Service: 12/13/2017 by email. The paper copies of the brief should be received by the court on or before 12/26/2017. Appellant Par Pharmaceutical, Inc.'s reply brief is due 12/27/2017. [483319] [CAB] [Entered: 12/18/2017 01:36 PM] (76)
Dec 13, 2017 41 TENDERED from Appellee Horizon Therapeutics, LLC. Title: OPENING BRIEF. Service: 12/13/2017 by email. [482514] [Robert Green] [Entered: 12/13/2017 06:30 PM] (76)
Oct 31, 2017 40 CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [39], ERROR: The contact information on Attorney Emer L. Simic's entry of appearance form does not match the information on counsel's ECF filer account. CORRECTION: ECF account information may be updated at www.pacer.gov, or counsel may file amended EOA reflecting the correct information. [471990] [CAB] [Entered: 10/31/2017 03:05 PM] (0)
Oct 30, 2017 39 Amended Entry of appearance for Emer L. Simic as of counsel for Appellee Horizon Therapeutics, LLC. Service: 10/30/2017 by email. [471537] [Emer Simic] [Entered: 10/30/2017 04:28 PM] (1)
Oct 30, 2017 38 Amended Entry of appearance for Matthew C. Phillips as of counsel for Appellee Horizon Therapeutics, LLC. Service: 10/30/2017 by email. [471535] [Emer Simic] [Entered: 10/30/2017 04:27 PM] (1)
Oct 30, 2017 37 Amended Entry of appearance for Robert F. Green as principal counsel for Appellee Horizon Therapeutics, LLC. Service: 10/30/2017 by email. [471534] [Emer Simic] [Entered: 10/30/2017 04:25 PM] (2)
Oct 24, 2017 36 Corrected Certificate of Interest for the Appellee Horizon Therapeutics, LLC. Service: 10/24/2017 by email. [470075] [Robert Green] [Entered: 10/24/2017 11:13 AM] (3)
Oct 24, 2017 35 NOTICE OF DEFICIENCY: The certificate of interest Document No. [32] filed by Appellee Horizon Therapeutics, LLC in 17-1451 is incomplete and therefore cannot be accepted for filing at this time. [CLERK'S NOTE: The Certificate of Interest form has been updated, as of 10/02/2017, to include Statement #5 regarding related cases. Please re-file using the updated Certificate of Interest form which is available on the court's website.] You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [470035] [CAB] [Entered: 10/24/2017 09:47 AM] (0)
Oct 24, 2017 34 **TEXT ONLY** ORDER granting motion to extend time to file appellee's principal brief [33] filed by Appellee Horizon Therapeutics, LLC. Appellee's brief due 12/13/2017. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [470031] [CAB] [Entered: 10/24/2017 09:44 AM] (0)
Oct 23, 2017 33 MOTION of Appellee Horizon Therapeutics, LLC to extend the time to 12/13/2017 to file the appellee/respondent/cross-appellant's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 10/23/2017 by email. [469809] [Robert Green] [Entered: 10/23/2017 01:38 PM] (6)
Oct 23, 2017 32 Corrected Certificate of Interest for the Appellee Horizon Therapeutics, LLC. Service: 10/23/2017 by email. [469806] [Robert Green] [Entered: 10/23/2017 01:31 PM] (0)
Oct 20, 2017 31 6 paper copies of the Opening Brief [30] received from Appellant Par Pharmaceutical, Inc.. [469322] [CW] [Entered: 10/20/2017 10:08 AM] (0)
Oct 17, 2017 29 Entry of appearance for Thomas K. Hedemann as of counsel for Appellant Par Pharmaceutical, Inc.. Service: 10/17/2017 by email. [468454] [Thomas Hedemann] [Entered: 10/17/2017 01:32 PM] (2)
Oct 16, 2017 30 BRIEF FILED for Appellant Par Pharmaceutical, Inc. [28]. Number of Pages: 50. Service: 10/16/2017 by email. The paper copies of the brief should be received by the court on or before 10/26/2017. Appellee Horizon Therapeutics, LLC's brief is due 11/27/2017. [469061] [CAB] [Entered: 10/19/2017 09:51 AM] (138)
Oct 16, 2017 28 TENDERED from Appellant Par Pharmaceutical, Inc.. Title: OPENING BRIEF. Service: 10/16/2017 by email. [468197] [Aziz Burgy] [Entered: 10/16/2017 06:22 PM] (138)
Oct 12, 2017 24 Entry of appearance for David H. Silverstein as of counsel for Appellant Par Pharmaceutical, Inc.. Service: 10/12/2017 by email. [467409] [David Silverstein] [Entered: 10/12/2017 03:07 PM] (2)
Oct 12, 2017 27 Certificate of Interest for the Appellant Par Pharmaceutical, Inc.. Service: 10/12/2017 by email. [467443] [Aziz Burgy] [Entered: 10/12/2017 03:48 PM] (3)
Oct 12, 2017 26 NOTICE OF DEFICIENCY: The certificate of interest Document No. [25] filed by Appellant Par Pharmaceutical, Inc. in 17-1451 is incomplete and therefore cannot be accepted for filing at this time. [CLERK'S NOTE: Question 2 on page 1 was not completed.] You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [467441] [CAB] [Entered: 10/12/2017 03:41 PM] (0)
Oct 12, 2017 25 Certificate of Interest for the Appellant Par Pharmaceutical, Inc.. Service: 10/12/2017 by email. [467413] [Aziz Burgy] [Entered: 10/12/2017 03:11 PM] (0)
Apr 6, 2017 23 ORDER filed. The motion [22] is granted. Par Pharmaceutical's opening brief is due October 16, 2017. Service: 04/06/2017 by clerk. [421973] [LMS] [Entered: 04/06/2017 10:48 AM] (2)
Mar 29, 2017 22 MOTION of Appellant Par Pharmaceutical, Inc. to extend the time to 10/16/2017 to file the appellant/petitioner's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 03/29/2017 by email. [420073] [Aziz Burgy] [Entered: 03/29/2017 04:02 PM] (6)
Feb 21, 2017 21 Amended Entry of appearance for Matthew C. Phillips as of counsel for Appellee Horizon Therapeutics, LLC. Service: 02/21/2017 by email. [409087] [Matthew Phillips] [Entered: 02/21/2017 12:10 PM] (1)
Feb 14, 2017 20 Certified list from the United States Patent and Trademark Office. Service: 02/14/2017 by email. Appellant/Petitioner's brief is due 04/17/2017. [407623] [CMP] [Entered: 02/15/2017 10:32 AM] (49)
Feb 3, 2017 19 Notice of intent to file corresponding briefs on CD-ROM for Appellee Horizon Therapeutics, LLC. Service: 02/03/2017 by email. [404699] [Emer Simic] [Entered: 02/03/2017 05:17 PM] (3)
Jan 26, 2017 18 CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:party notice Docket No. [17], ERROR: Document's caption does not follow official caption provided by the clerk. CORRECTION: The official caption provided by the clerk should be used on all future filings. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [402279] [CAB] [Entered: 01/26/2017 12:36 PM] (0)
Jan 24, 2017 17 Notice of intent to file corresponding briefs on CD-ROM for Appellant Par Pharmaceutical, Inc.. Service: 01/24/2017 by email. [401285] [Aziz Burgy] [Entered: 01/24/2017 11:23 AM] (3)
Jan 23, 2017 16 CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: Attorney Entry of Appearance for Robert F. Green Docket No. [10], lists contact information on the document that does not match the information associted with Counsel's CM/ECF account. CORRECTION: Counsel should promptly report a change in contact information with the PACER Service Center. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [400629] [CMP] [Entered: 01/23/2017 09:03 AM] (0)
Jan 19, 2017 15 Docketing Statement for the Appellee Horizon Therapeutics, LLC. Service: 01/19/2017 by email. [400536] [Matthew Phillips] [Entered: 01/19/2017 05:50 PM] (3)
Jan 19, 2017 14 Certificate of Interest for the Appellee Horizon Therapeutics, LLC. Service: 01/19/2017 by email. [400534] [Matthew Phillips] [Entered: 01/19/2017 05:49 PM] (1)
Jan 19, 2017 13 Entry of appearance for Matthew C. Phillips as of counsel for Appellee Horizon Therapeutics, LLC. Service: 01/19/2017 by email. [400533] [Matthew Phillips] [Entered: 01/19/2017 05:47 PM] (1)
Jan 19, 2017 12 Entry of appearance for Emer Simic as of counsel for Appellee Horizon Therapeutics, LLC. Service: 01/19/2017 by email. [400532] [Matthew Phillips] [Entered: 01/19/2017 05:46 PM] (1)
Jan 19, 2017 11 Entry of appearance for James B. Monroe as of counsel for Appellee Horizon Therapeutics, LLC. Service: 01/19/2017 by email. [400531] [Matthew Phillips] [Entered: 01/19/2017 05:45 PM] (1)
Jan 19, 2017 10 Entry of appearance for Robert F. Green as principal counsel for Appellee Horizon Therapeutics, LLC. Service: 01/19/2017 by email. [400530] [Matthew Phillips] [Entered: 01/19/2017 05:43 PM] (1)
Jan 19, 2017 9 Certificate of Interest for the Appellant Par Pharmaceutical, Inc.. Service: 01/19/2017 by email. [400366] [Aziz Burgy] [Entered: 01/19/2017 11:45 AM] (2)
Jan 19, 2017 8 NOTICE OF DEFICIENCY: The certificate of interest Document No. [6] filed by Appellant Par Pharmaceutical, Inc. in 17-1451 is incomplete [see question 2] and therefore cannot be accepted for filing at this time. Question two may not be left blank; if applicable, "none" may be used. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [400354] [CMP] [Entered: 01/19/2017 11:36 AM] (0)
Jan 19, 2017 7 Docketing Statement for the Appellant Par Pharmaceutical, Inc.. Service: 01/19/2017 by email. [400316] [Aziz Burgy] [Entered: 01/19/2017 10:40 AM] (4)
Jan 19, 2017 6 Certificate of Interest for the Appellant Par Pharmaceutical, Inc.. Service: 01/19/2017 by email. [400314] [Aziz Burgy] [Entered: 01/19/2017 10:38 AM] (0)
Jan 13, 2017 5 Transcript Purchase Order Form for the Appellant Par Pharmaceutical, Inc. indicating that a transcript is already on file. Service: 01/13/2017 by email. [399072] [Aziz Burgy] [Entered: 01/13/2017 01:52 PM] (2)
Jan 13, 2017 4 NOTICE OF DEFICIENCY: The Certificate of Compliance document Document No. [3] filed by Appellant Par Pharmaceutical, Inc. in 17-1451 is submitted using the incorrect event and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. CLERK'S NOTE: please re-enter the filing on the docket using the ECF event "Transcript Purchase Order Form Filed" in the Forms & Certificates category. [398916] [AT] [Entered: 01/13/2017 08:21 AM] (0)
Jan 12, 2017 3 Certificate of Compliance with Fed. R. App. P. 10(b) [The Transcript of Proceedings] for Appellant Par Pharmaceutical, Inc.. Service: 01/12/2017 by email. [398431] [Aziz Burgy] [Entered: 01/12/2017 05:35 PM] (2)
Jan 12, 2017 2 Entry of appearance for Aziz Burgy as principal counsel for Appellant Par Pharmaceutical, Inc.. Service: 01/12/2017 by email. [398426] [Aziz Burgy] [Entered: 01/12/2017 05:17 PM] (2)
Jan 5, 2017 1 Appeal docketed. Received: 12/29/2016. [396441] Entry of Appearance due 01/19/2017. Certificate of Interest is due on 01/19/2017. Docketing Statement due 02/06/2017. Certified List due on 02/14/2017. [CAB] [Entered: 01/05/2017 01:29 PM] (46)
Menu